The Angiotensin-receptor Blockers: From Antihypertensives to Cardiovascular All-round Medications in 10 Years?

ISSN： 0803-7051

Source： Blood Pressure, Vol.11, Iss.6, 2002-11, pp. : 328-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin Receptor Blockers in Hypertension and Cardiovascular Diseases

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 4, Iss. 1, 2006-01 ,pp. : 67-73

Bentham Science Publishers

Access to resources Recommend Favorite

Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?

By Neldam Steen

Future Cardiology, Vol. 6, Iss. 1, 2010-01 ,pp. : 129-135

Future Medicine

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Angiotensin Receptor Blockers and Target-Organ Protection Beyond Blood Pressure Control

By Riccardo Sarzani Paolo Dessì-Fulgheri Alessandro Rappelli

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 2, 2004-01 ,pp. : 65-73

Adis International

Access to resources Recommend Favorite

The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension

By Kjeldsen Sverre Narkiewicz Krzysztof Hedner Thomas

Blood Pressure, Vol. 18, Iss. 5, 2009-10 ,pp. : 240-241

Informa Healthcare

Access to resources Recommend Favorite